Review of studies on vaccine-induced myocarditis finds that the Science we're meant to be Following pervasively obfuscates the risk of the mRNA jabs for young men
Of the few studies that even attempt to assess the population-wide risk of myocarditis following vaccination, nearly three-fourths neglect to include the proper stratifiers | This review, co-authored by Vinay Prasad, sets out to assess the literature on the risk of myocarditis in young men following vaccination against SARS-CoV-2. Of 758 articles considered, the vast majority (89%) didn’t attempt any systematic risk assessment at all, and only 29 looked at population-wide risk. Of this meagre number, only eight properly stratified adverse events by sex, age, dose and vaccine manufacturer. This matters enormously, because the risk of myocarditis is heavily concentrated in men under forty following their second Pfizer or Moderna vaccination. ● By failing to break out these specific categories, scientists can write studies that overlook the risk of the vaccines for younger men, effectively by spreading their heightened risk across broader subgroups or even the whole population. ● The problem isn’t that a memo went out from Science Headquarters instructing researchers to cover up the obvious fact that the vaccines are clearly and beyond all cavil a bad deal for males under 40. It’s rather that science is subordinate to broader political, social and cultural forces, all of which incentivise research showing that the vaccines are safe and effective, and disincentivise research showing anything else. One kind of finding will get you promotion and grant funding, the other will – in the best case – simply be ignored. Cast in this light, the sheer paucity of studies looking at population-wide risks from vaccination in the first place begins to look deeply ominous. This is an entire area nobody wants to look into, for fear of what they might find.